Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Sold by Corton Capital Inc.

Corton Capital Inc. lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 35.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,276 shares of the pharmaceutical company’s stock after selling 701 shares during the quarter. Corton […]

Related Keywords

Canada ,Kristen Ambrose ,Amit Sachdev ,Corton Capital Inc ,Capital Research Global Investors ,Vertex Pharmaceuticals ,Canaccord Genuity Group ,Cantor Fitzgerald ,Royal Bank ,Quarter For Vertex Pharmaceuticals ,Securities Exchange Commission ,Vertex Pharmaceuticals Trading Down ,Exchange Commission ,Macquarie Group Ltd ,News Ratings For Vertex Pharmaceuticals Daily ,Winslow Capital Management ,Norges Bank ,Vertex Pharmaceuticals Incorporated ,Corton Capital ,Free Report ,Research Global Investors ,World Investors ,Capital Management ,Genuity Group ,Pharmaceuticals Trading Down ,Pharmaceuticals Incorporated ,Get Free Report ,Vertex Pharmaceuticals Daily ,Nasdaq Vrtx ,Vrtx ,Medical ,92532f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,